Target acquired: Selective autophagy in cardiometabolic disease.
about
Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis.Mitochondrial homeostasis in adipose tissue remodeling.Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.Sequestosome 1 Deficiency Delays, but Does Not Prevent Brain Damage Formation Following Acute Brain Injury in Adult Mice.Classical and alternative roles for autophagy in lipid metabolism.Defective Autophagy in Atherosclerosis: To Die or to Senesce?
P2860
Target acquired: Selective autophagy in cardiometabolic disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Target acquired: Selective autophagy in cardiometabolic disease.
@en
Target acquired: Selective autophagy in cardiometabolic disease.
@nl
type
label
Target acquired: Selective autophagy in cardiometabolic disease.
@en
Target acquired: Selective autophagy in cardiometabolic disease.
@nl
prefLabel
Target acquired: Selective autophagy in cardiometabolic disease.
@en
Target acquired: Selective autophagy in cardiometabolic disease.
@nl
P2860
P1433
P1476
Target acquired: Selective autophagy in cardiometabolic disease.
@en
P2093
Ismail Sergin
Xiangyu Zhang
P2860
P356
10.1126/SCISIGNAL.AAG2298
P577
2017-02-28T00:00:00Z